Evidence map›Paper›PMID 41148798›Full record

ReviewCells2025

Plasma Membrane Epichaperome-Lipid Interface: Regulating Dynamics and Trafficking.

Haneef Ahmed Amissah, Ruslana Likhomanova, Gabriel Opoku, Tawfeek Ahmed Amissah, Zsolt Balogi, Zsolt Török, László Vigh, Stephanie E Combs, Maxim Shevtsov

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haneef Ahmed AmissahDepartment of Medical Biology and Biotechnology, Institute of Life Sciences and Biomedicine, FEFU Campus, Far Eastern Federal University, 690922 Vladivostok, Russia.ORCID 0000-0002-1395-4546
Ruslana LikhomanovaLaboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), 194064 Saint Petersburg, Russia.ORCID 0000-0001-8347-7274
Gabriel OpokuDepartment of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama 700-8558, Japan.ORCID 0000-0001-6465-997X
Tawfeek Ahmed AmissahDepartment of Medical Laboratory Science, Faculty of Health and Allied Sciences, Koforidua Technical University, Koforidua EN-112-3991, Eastern Region, Ghana.
Zsolt BalogiInstitute of Biochemistry and Medical Chemistry, Medical School, University of Pécs, 7624 Pécs, Hungary.
Zsolt TörökInstitute of Biochemistry, HUN-REN Biological Research Centre, 6726 Szeged, Hungary.
László VighInstitute of Biochemistry, HUN-REN Biological Research Centre, 6726 Szeged, Hungary.
Stephanie E CombsDepartment of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany.
Maxim ShevtsovLaboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), 194064 Saint Petersburg, Russia.ORCID 0000-0002-8539-2239

Funding

Validating establishment of functional safety in skin interface with deeply porous transcutaneous pylon for direct skeletal attachment of limb prosthesesR44AR079960 · NIAMS · POLY-ORTH INTERNATIONAL · PI PITKIN, MARK · 2021 to 2022
$1.7M
Deutsche Forschungsgemeinschaft DFG funding program Open Access PublishingMinistry of Science and Higher Education of the Russian Federation 075-15-2022-301NIAMS NIH HHS R44 AR079960
6 · The paper itself

Abstract

The plasma membrane (PM) of eukaryotic cells plays a key role in the response to stress, acting as the first line of defense against environmental changes and protecting cells against intracellular perturbations. In this work, we explore how membrane-bound chaperones and membrane lipid domains work together to shape plasma membrane properties-a partnership we refer to as the "epichaperome-plasma membrane lipid axis." This axis influences membrane fluidity, curvature, and domain organization, which in turn shapes the spatial and temporal modulation of signaling platforms and pathways essential for maintaining cellular integrity and homeostasis. Changes in PM fluidity can modulate the activity of ion channels, such as transient receptor potential (TRP) channels. These changes also affect processes such as endocytosis and mechanical signal transduction. The PM proteome undergoes rapid changes in response to membrane perturbations. Among these changes, the expression of heat shock proteins (HSPs) and their accumulation at the PM are essential mediators in regulating the physical state and functional properties of the membrane. Because of the pivotal role in stress adaptation, HSPs influence a wide range of cellular processes, which we grouped into three main categories: (i) mechanistic insights, differentiating in vitro (liposome, reconstituted membrane systems) and in vivo evidence for HSP-PM recruitment; (ii) functional outputs, spanning how ion channels are affected, changes in membrane fluidity, transcytosis, and the process of endocytosis and exosome release; and (iii) pathological effects, focusing on how rewired lipid-chaperone crosstalk in cancer drives resistance to drugs through altered membrane composition and signaling. Finally, we highlight Membrane Lipid Therapy (MLT) strategies, such as nanocarriers targeting specific PM compartments or small molecules that inhibit HSP recruitment, as promising approaches to modulate the functional stability of epichaperome assembly and membrane functionality, with profound implications for tumorigenesis.

Indexed as

Cell MembraneMembrane LipidsAnimalsHeat-Shock ProteinsHumansMembrane FluidityProtein TransportSignal TransductionHeat-Shock ProteinsMembrane Lipidsepichaperomeheat shock proteinslipidomicsmembrane-bound heat shock proteinsmembrane lipidsplasma membrane

Identifiers

PMID41148798
PMCPMC12564747

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.